Insights

Nasal Vaccine Focus Target opportunities in intranasal vaccine collaborations and partnerships leveraging BlueWillow’s NanoVax adjuvant platform for respiratory infections, sexually transmitted diseases, and food allergies.

Clinical-Stage Partnerships Leverage BlueWillow’s clinical-stage pipeline including Peanut Allergy, HSV-2, Covid-19, Anthrax, Pandemic Flu and RSV to explore co-development, licensing, or strategic alliances with biopharma developers and contract research organizations.

Global Immunity Platform Position NanoVax as a mucosal immunity solution with systemic effects to address unmet needs in both prevention and potential therapeutic applications, appealing to gov’t programs and international aid opportunities.

Strategic Alliances Explore partnerships around distribution, manufacturing scalability, and regulatory support, given BlueWillow’s clinical focus and recent market presence through news about acquisitions and rebranding in the ecosystem.

Market Readiness Capitalize on a proven revenue range and funding footprint to pursue grant co-development, milestone-based deals, and joint ventures with mid to large biotech players seeking next-gen nasal vaccine platforms.

BlueWillow Biologics, Inc. Tech Stack

BlueWillow Biologics, Inc. uses 8 technology products and services including iCIMS, WordPress Super Cache, Microsoft Outlook, and more. Explore BlueWillow Biologics, Inc.'s tech stack below.

iCIMS

Applicant Tracking Systems

WordPress Super Cache

Caching

Microsoft Outlook

Google Fonts API

Font Scripts

Microsoft Office

Office Suites

X-Content-Type-Options

Web & Portal Technology

Piwik PRO Core

Web Analytics

Apache HTTP Server

Web Servers

BlueWillow Biologics, Inc. Email Formats	Example	Percentage
First.Last@bluewillow.com	John.Doe@bluewillow.com	92%
Last@bluewillow.com	Doe@bluewillow.com	8%

BlueWillow Biologics, Inc. Email Formats

Example

Percentage

First.Last@bluewillow.com

John.Doe@bluewillow.com

92%

Last@bluewillow.com

Doe@bluewillow.com

Frequently Asked Questions

What is BlueWillow Biologics, Inc.'s phone number?

You can contact BlueWillow Biologics, Inc.'s main corporate office by phone at

+1-734-302-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is BlueWillow Biologics, Inc.'s official website and social media links?

BlueWillow Biologics, Inc.'s official website is bluewillow.com and has social profiles on LinkedIn.

What is BlueWillow Biologics, Inc.'s SIC code NAICS code?

BlueWillow Biologics, Inc.'s SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does BlueWillow Biologics, Inc. have currently?

As of July 2026, BlueWillow Biologics, Inc. has approximately 22 employees across 2 continents, including North AmericaAsia. Key team members include Vice President: S. G.Manager: B. W.Principal: L. H.. Explore BlueWillow Biologics, Inc.'s employee directory with LeadIQ.

What industry does BlueWillow Biologics, Inc. belong to?

BlueWillow Biologics, Inc. operates in the Biotechnology Research industry.

What technology does BlueWillow Biologics, Inc. use?

BlueWillow Biologics, Inc.'s tech stack includes iCIMSWordPress Super CacheMicrosoft OutlookGoogle Fonts APIMicrosoft OfficeX-Content-Type-OptionsPiwik PRO CoreApache HTTP Server.

What is BlueWillow Biologics, Inc.'s email format?

BlueWillow Biologics, Inc.'s email format typically follows the pattern of First.Last@bluewillow.com. Find more BlueWillow Biologics, Inc. email formats with LeadIQ.

How much funding has BlueWillow Biologics, Inc. raised to date?

As of July 2026, BlueWillow Biologics, Inc. has raised $86M in funding. The last funding round occurred on Sep 26, 2018.

BlueWillow Biologics, Inc.

Q: How many employees does BlueWillow Biologics, Inc. have currently?

BlueWillow Biologics, Inc. has approximately 22 employees.

Q: What technology does BlueWillow Biologics, Inc. use?

BlueWillow Biologics, Inc.'s tech stack includes gstatic.com, PHP, Really Simple SSL & Security, Microsoft, Open Graph.

Q: What is BlueWillow Biologics, Inc.'s NAICS code?

BlueWillow Biologics, Inc.'s NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Biotechnology ResearchUnited States11-50 Employees

BlueWillow Biologics, Inc. is a United States-based biotechnology research company focused on developing intranasal vaccines and adjuvants. Its approach aims to stimulate mucosal immunity in the nasal passages while also eliciting systemic immune responses, with a pipeline including Peanut Allergy, HSV-2, Covid-19, Anthrax, Pandemic Flu and RSV. The organization operates at the clinical stage, pursuing safe and effective nasal vaccines to address global health challenges.

In 2022 the company was acquired by LimeWire GmbH. Based in the United States and active in biotechnology research, BlueWillow targets protection from respiratory infections, sexually transmitted diseases, and food allergies through its intranasal vaccine programs.

Insights

Similar companies to BlueWillow Biologics, Inc.

Immune-Onc Therapeutics

CytoDyn

Osivax

Oncorus